On the other hand, a higher expression of CXCL16 is associated with better overall survival in patients with colorectal cancer [153], gastric carcinoma [173], non-small cell lung cancer [76], and renal cell carcinoma [14]. This evidence concerns the gene CXCL16 and renal cell carcinoma.